VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics

Simple item page

Files

Original bundle

Now showing 1 - 1 of 1

Name:: VITALITY ALS a phase III trial of tirasemtiv a selective fast skeletal muscle troponin activator as a potential treatment for patients with.pdf
Size:: 522.32 KB
Format:: Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1

Name:: license.txt
Size:: 3.5 KB
Format:: Item-specific license agreed upon to submission
Description:

Collections

Clinical Medicine (Scholarly Publications)
RSS Feeds